US PTO granting Probiodrug a Further Medical Use Patent for the Inhibition of the Enzyme Glutaminyl Cyclase (QC)

Probiodrug to Present an Update on QC Inhibition as Potential New Treatment for Alzheimer’s Disease at the Society for Neuroscience Meeting 2008, Nov. 15-19, 2008, Washington, DC
Probiodrug to Present an Update on QC Inhibition as Potential New Treatment for Alzheimer’s Disease at the 9th international conference AD/PD 2009 in Prague, Czech Republic, March 11-15.